文献速递冠心病外科

冠状动脉旁路移植术后两年:外支架与隐静脉移植物疾病进展的多中心随机试验

External stenting and disease progression in saphenous vein grafts two years after coronary artery bypass grafting: A multicenter randomized trial.
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-04-21

该多中心随机试验纳入184例接受孤立冠状动脉旁路移植术的患者,每例随机将一根隐静脉移植物置入外支架,另一根作为对照。2年时造影显示总体通畅率相似,但外支架组Fitzgibbon通畅等级显著改善,且血管内超声显示内膜增生面积和厚度显著减少。外支架能否最终改善长期通畅率尚不明确。

核心结论

  • 冠状动脉旁路移植术后2年,外支架改善隐静脉移植物的Fitzgibbon通畅等级并显著减少内膜增生面积和厚度。
  • 外支架能否最终改善长期通畅率尚不清楚。

研究设计与样本

  • 多中心随机试验,纳入14个欧洲中心的184例接受孤立冠状动脉旁路移植术的患者,每例使用1根胸廓内动脉移植物和至少2根额外的隐静脉移植物。
  • 每例患者随机将1根隐静脉移植物置入外支架,另1根未置入支架的隐静脉移植物作为对照。
  • 主要终点为造影评估的隐静脉移植物Fitzgibbon通畅等级,次要终点为预设亚组2年时血管内超声评估的隐静脉移植物内膜增生。

主要发现

  • 2年时128例患者完成造影,预设亚组全部51例完成血管内超声。

临床怎么用

  • 对于接受冠状动脉旁路移植术并使用隐静脉移植物的患者,外支架可改善2年时移植物的Fitzgibbon通畅等级并减少内膜增生。
  • 外支架对长期通畅率和临床硬终点的影响尚不明确,需进一步随访。

局限性

  • 2年造影随访仅完成128例,存在一定失访。
  • 血管内超声仅在预设亚组(n=51)中进行。
  • 长期通畅率和临床结局尚未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Little data exist regarding the potential of external stents to mitigate long-term disease progression in saphenous vein grafts. We investigated the effect of external stents on the progression of saphenous vein graft disease. METHODS: A total of 184 patients undergoing isolated coronary artery bypass grafting, using an internal thoracic artery graft and at least 2 additional saphenous vein grafts, were enrolled in 14 European centers. One saphenous vein graft was randomized to an external stent, and 1 nonstented saphenous vein graft served as the control. The primary end point was the saphenous vein graft Fitzgibbon patency scale assessed by angiography, and the secondary end point was saphenous vein graft intimal hyperplasia assessed by intravascular ultrasound in a prespecified subgroup at 2 years. RESULTS: Angiography was completed in 128 patients and intravascular ultrasound in the entire prespecified cohort (n = 51) at 2 years. Overall patency rates were similar between stented and nonstented saphenous vein grafts (78.3% vs 82.2%, P = .43). However, the Fitzgibbon patency scale was significantly improved in stented versus nonstented saphenous vein grafts, with Fitzgibbon patency scale I, II, and III rates of 66.7% versus 54.9%, 27.8% versus 34.3%, and 5.5% versus 10.8%, respectively (odds ratio, 2.02; P = .03). Fitzgibbon patency scale was inversely related to saphenous vein graft minimal lumen diameter, with Fitzgibbon patency scale I, II, and III saphenous vein grafts having an average minimal lumen diameter of 2.62 mm, 1.98 mm, and 1.32 mm, respectively (P < .05). Externally stented saphenous vein grafts also showed significant reductions in mean intimal hyperplasia area (22.5%; P < .001) and thickness (23.5%; P < .001). CONCLUSIONS: Two years after coronary artery bypass grafting, external stenting improves Fitzgibbon patency scales of saphenous vein grafts and significantly reduces intimal hyperplasia area and thickness. Whether this will eventually lead to improved long-term patency is still unknown.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Taggart DP, Gavrilov Y, Krasopoulos G, et al. External stenting and disease progression in saphenous vein grafts two years after coronary artery bypass grafting: A multicenter randomized trial. J Thorac Cardiovasc Surg. 2021. PMID: 34024615. doi:10.1016/j.jtcvs.2021.03.120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。